VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 128 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 7.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,026,000 | -10.2% | 57,310 | -18.3% | 0.02% | -10.5% |
| Q2 2017 | $1,143,000 | -10.4% | 70,104 | -23.0% | 0.02% | +5.6% |
| Q1 2017 | $1,275,000 | -6.3% | 91,049 | +6.7% | 0.02% | 0.0% |
| Q4 2016 | $1,361,000 | -2.8% | 85,307 | +1.4% | 0.02% | +20.0% |
| Q3 2016 | $1,400,000 | +88.2% | 84,111 | +26.5% | 0.02% | +114.3% |
| Q2 2016 | $744,000 | -14.9% | 66,478 | -36.4% | 0.01% | -12.5% |
| Q1 2016 | $874,000 | +64.0% | 104,574 | +121.3% | 0.01% | +100.0% |
| Q3 2015 | $533,000 | -78.1% | 47,258 | -75.9% | 0.00% | -76.5% |
| Q4 2013 | $2,437,000 | +451.4% | 196,358 | +386.0% | 0.02% | +466.7% |
| Q3 2013 | $442,000 | +68.1% | 40,407 | +24.3% | 0.00% | +50.0% |
| Q2 2013 | $263,000 | – | 32,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 728,000 | $10,425,000 | 5.01% |
| Signpost Capital Advisors, LP | 828,793 | $11,868,000 | 4.38% |
| Palo Alto Investors LP | 3,786,908 | $54,229,000 | 3.18% |
| RTW INVESTMENTS, LP | 500,000 | $7,160,000 | 2.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,139,787 | $59,282,000 | 2.13% |
| First Light Asset Management, LLC | 229,818 | $3,291,000 | 1.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,461,305 | $35,246,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 175,000 | $2,506,000 | 0.92% |
| WALL STREET ASSOCIATES | 655,800 | $9,391,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 368,390 | $5,275,000 | 0.90% |